Hyundai Bioscience Co Ltd
KOSDAQ:048410
Intrinsic Value
The intrinsic value of one Hyundai Bioscience Co Ltd stock under the Base Case scenario is 615.21 KRW. Compared to the current market price of 10 870 KRW, Hyundai Bioscience Co Ltd is Overvalued by 94%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Hyundai Bioscience Co Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Hyundai Bioscience Co Ltd
Balance Sheet Decomposition
Hyundai Bioscience Co Ltd
Current Assets | 9.1B |
Cash & Short-Term Investments | 8.1B |
Receivables | 470.4m |
Other Current Assets | 546.4m |
Non-Current Assets | 61.9B |
Long-Term Investments | 23.8B |
PP&E | 2.6B |
Intangibles | 33.2B |
Other Non-Current Assets | 2.3B |
Free Cash Flow Analysis
Hyundai Bioscience Co Ltd
KRW | |
Free Cash Flow | KRW |
Earnings Waterfall
Hyundai Bioscience Co Ltd
Revenue
|
15.1B
KRW
|
Cost of Revenue
|
-3.2B
KRW
|
Gross Profit
|
11.9B
KRW
|
Operating Expenses
|
-11.1B
KRW
|
Operating Income
|
791m
KRW
|
Other Expenses
|
-7.7B
KRW
|
Net Income
|
-6.9B
KRW
|
Profitability Score
Profitability Due Diligence
Hyundai Bioscience Co Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Hyundai Bioscience Co Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hyundai Bioscience Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Hyundai Bioscience Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hyundai Bioscience Co Ltd
Dividends
Current shareholder yield for Hyundai Bioscience Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Hyundai Bioscience Co Ltd stock under the Base Case scenario is 615.21 KRW.
Compared to the current market price of 10 870 KRW, Hyundai Bioscience Co Ltd is Overvalued by 94%.